Fwd: FDA Approves First Bone Marrow Stimulator to Treat Immune-Related Low Platelet Counts

[Guest guest]

Note: forwarded message attached. Jeanne

FDA Approves First Bone Marrow Stimulator to Treat Immune-Related Low Platelet CountsFri, 22 Aug 2008 11:22:00 -0500

The U.S. Food and Drug Administration today approved Nplate (romiplostim), the first product that directly stimulates the bone marrow to produce needed platelets in patients with a rare blood disorder that can lead to serious bleeding.

Update your subscriptions, modify your e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact support@....

This service is provided to you at no charge by U.S. Food & Drug Administration (FDA).

GovDelivery, Inc. sending on behalf of U.S. Food & Drug Administration (FDA)

· 5600 Fishers Lane

· Rockville MD 20857

·